Induction by the 4-quinolone group of antibacterial drugs of the umuC gene, the SOS function most involved in error-prone DNA repair (together with umuD ), was assessed in a strain of Escherichia coli harbouring a umuC: : lac2 gene fusion. All 4-quinolones tested induced this umuC: : lac2 fusion, with maximum induction at 4-quinolone concentrations close to their minimum inhibitory concentrations for this strain, and the SOS Inducing Potential (SOSIP) was closely related to antibacterial activity. Mitomycin C, a known mutagen, was a slightly better inducer (in terms of SOSIP) than any of the quinolones. In contrast, induction by 4-quinolones of the sfiA (suZA) gene, an SOS function involved in cell division inhibition, was better than induction by mitomycin C in an E . coli strain harbouring an sf iA : : lac2 gene fusion. The umuC gene fusion was induced at lower concentrations of 4-quinolone than was the sfiA gene fusion.
Introduction
The ability of the 4-quinolone antibacterial drugs to induce the SOS response in Escherichia coli is well documented. 1- 4 Investigations have concentrated mainly on the expression of the sulA (sfiA) gene, which codes for a cell division inhibitor.'-3 Since SOS processing of DNA is e r r~r -p r o n e ,~'~ it has been suggested that quinolones may be (weakly) mutagenic. ' 37 ' However, insufficient attention has been paid to the fact that the products of the umuDC genes are a pre-requisite for SOS-mediated mutagene-S~S .~,~? *-lo Furthermore, according to current theory, some SOS genes such as sulA are repressed less strongly than others such as umuDC. 6 Therefore, a weak inducing signal will lead to derepression and subsequent expression of sulA but not umuDC. We have tried to establish whether quinolones are capable of producing a sufficiently strong inducing signal to permit expression of the umuC gene as measured by the synthesis of fl-galactosidase in an E. coli strain harbouring a urnuC::lacZ gene fusion," and have compared umuC induction with that of suZA.
Antibacterial agents
The following quinolones were used in this study: ciprofloxacin (Bayer), sparfloxacin, pefloxacin (Rhone Poulenc), ofloxacin (Hoechst), tosufloxacin (Lederle), difloxacin, temafloxacin (Abbott), fleroxacin (Roche), acrosoxacin, nalidixic acid (Sterling Winthrop) and enoxacin (Warner Lambert). The compounds were initially dissolved in 0 . 0 1~ NaOH and diluted to the required concentrations in sterile distilled water. Mitomycin C (Sigma) was dissolved and diluted in sterile distilled water.
MIC determinations
From overnight cultures of the strains, 10-pl were transferred into 2.5 ml of brain heart infusion (BHI) broth (to give 104-105 cfulml) containing appropriate concentrations of the quinolones. The mixtures were incubated for 16h at 30°C and the tubes were examined for growth. The MIC of each quinolone was taken to be the lowest concentration at which there was no visible growth. Table I . Bacterial strains used in this study
Materials and methods

Strains Characteristics
Bacterial strains
Strains used in this study are listed in table I. Strain GW 1 104 is temperature-sensitive, so all experiments were performed at 30°C. 
Induction of SOS genes
Bufers and reagents for SOS induction. B buffer was Na2HP04 16.1 g, NaH2P04. H 2 0 5.5 g, KClO.75 g, MgS04. 7H,O 0.25 g, sodium dodecyl sulphate (SDS) I g, /I-mercaptoethanol 2-7 ml, distilled H 2 0 to lL, adjusted to pH 7. ONPG solution (5 mg/ml) was ONPG 500mg/100ml in phosphate buffer, pH 7. Phosphate buffer, pH 7 was 0.1 M Na2HP04. 7H20 61 ml and 0.1 M NaH2P04. H 2 0 39 ml.
The test strains were grown overnight in BHI broth at 30°C and 0.1-ml volumes were then diluted in 5 ml of BHI broth and incubated at their respective temperatures in a shaking waterbath until the cultures reached a density of 2 x lo8 cfu/ml (c. 3 h at 30°C). At this time, ranges of concentrations of 4-quinolones or mitomycin C were mixed with the cultures and incubated for 3 h at 30°C. The P-galactosidase activity was then measured.
The assay procedure for P-galactosidase was similar to that described previously. ' Samples (0.3 ml) of the reaction mixtures were added to 2.7 ml of B buffer" and incubated at 37°C for 10 min for the temperature to equilibrate. The P-galactosidase assay was then initiated by adding 0.6 ml of ONPG solution. The assay was terminated after an appropriate time for colour development (10-90 min) by adding 2 ml of 1 M Na2C03 solution. The absorbance at 420nm (A420) was read against a colorimeter blank in which the bacterial culture was replaced by BHI broth. Time of colour development was adjusted so that the final A420 was approximately 0.1-0-4. Units of enzyme activities were calculated according to the formula used by Miller: Miller Units of P-galactosidase activity = ---where, A420 and A550 were the absorbance values at the relevant wavelength after t min, and v was the reaction volume. A600 was the initial absorbance of the culture at 600 nm. The SOS Inducing Potential (SOSIP)'2 for each compound is the slope of the linear region of the doseresponse curve. It is a single parameter that represents the number of P-galactosidase units induced/pmol of compound tested.
Results
The induction of the umuC::ZacZ fusion by 4-quinolones is shown in figs. 1-4. Mitomycin C was included as an example of a known mutagen. All the 4-quinolones tested induced umuC, but differences were evident in the levels of induction and the ranges of concentrations over which the various quinolones induced umuC. These differences are reflected in their SOSIPs (table 11) . Mitomycin C produced twice as much P-galactosidase ( fig. 4) as the most active quinolone, pefloxacin ( fig. 3) , at their optimum concentrations. The concentration of quinolone at which 
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. maximum induction occurred correlated well with, and was close to, the MIC of the respective drug against this strain (GW1104) (fig. 5 ). The SOSIP of each quinolone correlated even better than the maximum inducing concentration with the respective MIC ( fig. 6 ).
A comparison of the induction of umuC and sulA by ciprofloxacin and mitomycin C is shown in fig. 7 . The concentration of ciprofloxacin or mitomycin C required to induce umuC was lower than that required to induce sulA ; ciprofloxacin induced approximately the same level of sulA as mitomycin C , whereas mitomycin C induced greater levels of umuC than ciprofloxacin at their optimum concentrations as measured by the respective lac2 fusions. The level of sulA induction was at least one order of magnitude higher than the level of umuC induction. It should be noted also that lower concentrations of ciprofloxacin than of mitomycin C are capable of inducing sulA whereas both compounds induce umuC at similar concentrations. This is reflected by the SOSIPs of these compounds for both fusions (table 11) . 
Discussion
An E. coZi SUZA fusion strain has been proposed as a screen for potential mutagenicity. ' 2 9 14* However, measurement of sulA expression alone will give no indication of the extent of induction of the various SOS genes nor of the mutagenic potential of the inducing treatment. Our results clearly show that the 4-quinolones are capable of inducing the umuC gene an SOS function involved in error-prone repair and mutagene~is.~. UmuD shares a common promotor and operator with umuC;6 hence, induction of the umuC fusion is effectively also that of urnuD. According to current understanding, LexA repressor is strongly bound to the umuC promotor region and requires a strong SOS inducing signal for derepression and subsequent expression of the gene.6 Clearly, 4-quinolones are capable of generating such a signal. Induction of the umuC gene is probably a better indicator of mutagenic potential than is induction of sulA. This argument is supported by the fact that mitomycin C exhibits a lower SOSIP than ciprofloxacin with sulA, but a higher SOSIP with umuC(tab1e 11). Such a reversal in induction potency has been observed also with ultraviolet light and nalidixic acid. l 6 Nevertheless, problems may arise in the use of the umuC: : lac2 fusion as a screen for mutagenic potential. One disadvantage is that induced levels of umuC are relatively low (at least in a lac2 fusion) and the fusion may not be sufficiently sensitive to differentiate mutagenic and non-mutagenic compounds accurately.
An interesting paradox is evident on close examination of fig. 7 . If umuC is repressed more strongly than sulA,6 low concentrations of ciprofloxacin (or mitomycin C) would be expected to induce sulA but not umuC. However, umuC is induced at concentrations about 10-fold lower than those which are capable of inducing sulA. This implies that some other mechanism must regulate the expression of these SOS genes, possibly some form of attenuation. Strain differences are unlikely as strains GC4415 and GW 1 104 are equally sensitive to ciprofloxacin (MIC 0.01 mg/L). SuZA induction is maximal at quinolone concentrations approximately 10 x MIC, ' whereas umuC induction is maximal at the MIC. The implications of this finding are at present unclear.
The measurement of SOSIP was an attempt to classify the different quinolones in order of potential ability to induce umuC, because interpretation of induction curves was not easy. For example, enoxacin maximally induced umuC at a lower concentration than pefloxacin, yet pefloxacin induced approximately 2.5 times as much P-galactosidase ( fig. 3) . Therefore, it was difficult, if not impossible, to decide which of these parameters was more indicative of relative umuC inducing ability. The SOSIP takes both factors into account. Previous investigations of SOS induction by assessing expression of sfiAlY3 have ranked the 4-quinolones in the order of SOS inducing potential ciprofloxacin > fleroxacin = pefloxacin > nalidixic acid. Our SOSIP data (table 11) broadly agree with this classification.
The SOSIP for umuC (table 11) may correlate with the potential mutagenicity of the 4-quinolones in bacteria with a functional SOS response, as proposed for s~2A.l~ A previous report on mutagenicity of 4-quinolones found that the order was ciprofloxacin > norfloxacin > nalidixic acid. If SOSIP were to correlate with mutagenicity, sparfloxacin, for example, would be expected to exhibit a stronger mutagenic effect than pefloxacin because it has a higher SOSIP value (table 11) . Alternatively, SOS-mediated mutagenesis may require only a certain threshold level of umuC gene product, induction above this threshold resulting in mutagenesis. In this case, all 4-quinolones capable of achieving this level of induction might be expected to be approximately equally mutagenic, assuming that all are capable of mutagenesis only via SOS-processed DNA damage and do not cause other forms of direct DNA damage. It has been suggested by others that it is not valid to predict potential mutagenicity from SOS induction alone. Preliminary experiments in our laboratory suggest that there is no correlation between SOSIP and mutagenicity at least for 4-quinolones.
